Below are several selected presentations and posters which can be downloaded as PDFs.
Annual North American Cystic Fibrosis Conference
- Denver, CO, USA
October 18-20, 2018. Scientific poster: Results From Two Completed Phase I Studies With POL6014-A Novel Inhaled Neutrophil Elastase Inhibitor
23rd International Congress of the World Muscle Society (WMS) – Mendoza, Argentina
October 2-6, 2018. Scientific poster presentations.
15th International Congress on Neuromuscular Diseases - ICNMD (Vienna, Austria)
July 6-10, 2018. Scientific poster presentations.
2018 Parent Project Muscular Dystrophy Annual Conference (Scottsdale, Arizona, USA)
June 28-30, 2018. Presentation by Kristina Sjöblom Nygren, CMO
16th International Conference on Duchenne and Becker Muscular Dystrophy (Rome)
February 16-18, 2018. Presentation by Thomas Meier, CEO
American Thoracic Society 113th Annual Conference (Washington, DC)
May 22, 2017. Poster presentation: Correlation between volume- and flow-related pulmonary function outcomes in patients with DMD
May 23, 2017. Poster presentation: Effect of Idebenone on Bronchopulmonary Adverse Events and Hospitalizations in Patients with Duchenne Muscular Dystrophy (DMD)
ARVO - Annual Meeting of The Association for Research in Vision and Ophthalmology (Seattle)
May 4, 2016. Poster presentation by Shabir Hasham: Treatment of visual impairment in patients with Leber’s hereditary optic neuropathy using idebenone (Raxone®)
EUNOS - 12th Meeting of European Neuro-Ophthalmological Society (Ljubljana)
June 24, 2015. Presentation by Günther Metz: Clinical experience with idebenone (Raxone®) in the treatment of patients with Leber’s hereditary optic neuropathy
EVER - Annual Meeting of The European Association for Vision and Eye Research (Nice)
October 8, 2015. Poster presentation by Claudia Catarino: Clinical experience with idebenone (Raxone®) in the treatment of patients with Leber’s hereditary optic neuropathy (LHON)